News of the WeekPUBLIC HEALTH

Anthrax Vaccine Begins a New Round of Tests

See allHide authors and affiliations

Science  18 Jan 2002:
Vol. 295, Issue 5554, pp. 427-429
DOI: 10.1126/science.295.5554.427

You are currently viewing the summary.

View Full Text

Summary

Since 1999, Congress has given the Centers for Disease Control and Prevention (CDC) in Atlanta $36 million to study the 32-year-old anthrax vaccine, responding to complaints from members of the armed services and problems at the sole manufacturing plant, which has been compelled to suspend production since 1998 for safety checks. Researchers planning the CDC studies briefed an oversight panel at the Institute of Medicine in Washington, D.C., last week--and got a mixed review.